In addition, a recent study on NSCLC patients showed that tumor-infiltrating NK cells express PD-1, as well as other inhibitory checkpoints, and that their dysfunction correlates with increasing levels of membrane PD-1 expression [43]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.